Citigroup (NYSE: C) — Fundamental Deep Dive Analysis
Equity Research · Fundamental Deep Dive
Citigroup (NYSE: C) — Fundamental Deep-Dive Analysis
Operational turnaround where 2 years of restructuring convert into profitability. H1 FY26 RoTCE reached 13%, exceeding FY26 guidance early.
1. Executive Summary
Citigroup " + → " . FY2023 Trough(ROE 4.5%, Efficiency 71.4%) 2 , 2026 .
Q2'26 EPS
$3.15
+15.8%
Q2'26 RoTCE
13.0%
FY26 10~11%
Efficiency
57.4%
YoY -530bps
FWD P/E (FY27)
10.4x
P/B
1.16x
JPM 2.65 · MS 3.19
$30B Buybacks
Q2 $4B · Dividend +12%
CET1
12.8%
11.6% +120bps
BUY
16/21 · +16%
Key Thesis — What Has the Market Priced In?
2026 C YTD +14.5%, 1 +45% " " . . : Q2'26 Annualized ROE 11.4%·RoTCE 13% , P/B 1.16x x(P/B ~1.3x, Gordon ) 10% . ROE 10% P/B 0.94x . " " .
2. Recent Earnings — Q2'26 Revenue Reaches 10-Year High
7/14 Q2'26 . $24.77B(+14% YoY, 10 ), Net Income $5.83B(+45%), Diluted EPS $3.15(+61%). EPS $2.72 +15.8% , GS(+44.3%) .
| Q2'26 | Q2'25 | YoY | Notes | |
|---|---|---|---|---|
| Total Revenue | $24,766M | $21,731M | +14% | 10 |
| Total Op Expenses | $14,215M | $13,551M | +5% | Efficiency 57.4% |
| NCL | $2,404M | $2,228M | +8% | NCL |
| Net Income | $5,831M | $4,013M | +45% | H1 $11.6B |
| Diluted EPS | $3.15 | $1.96 | +61% | $2.72 +15.8% |
| RoTCE | 13.0% | 8.7% | +430bps | FY26 10~11% |
| CET1 | 12.8% | 13.5% | -70bps | 11.6% +120bps |
: H1'26 Net Income $11.6B FY2025 ($14.3B) 81% . (-20% QoQ ) FY26 EPS $11.08 .
Segment Performance — 3 Pillars of Growth
| Segment | Q2'26 Revenue | YoY | Net Income | YoY | RoTCE |
|---|---|---|---|---|---|
| Services (TTS+) | $6,382M | +18% | $2,584M | +51% | 30.9% |
| Markets (FICC+Equities) | $7,007M | +17% | $2,387M | +39% | 18.4% |
| Banking (IB+) | $1,954M | +31% | $350M | +276% | 18.0% |
| Wealth | $3,177M | +13% | $583M | +10% | 11.2% |
| USCC ( ) | $4,521M | +1% | $852M | -6% | 22.0% |
| All Other | $1,737M | +9% | -$923M | — | — |
- Services — : $1 , RoTCE 30.9%( ), NII +18%, AUCA +21%. e-· .
- Markets — 10 : Equities +45%, Commodities . IB +44%(DCM +65%, ECM +92%).
- USCC — +65% (537.6), American Airlines co-brand . -47% .
3. Turnaround Progress — Acceleration from FY23 Trough
2019 $19.4B Net Income(ROE 10%) C 2020 2023 ROE 4.5% . :
| FY2019 | FY2022 | FY2023 (Trough) | FY2024 | FY2025 | H1'26 Annualized | |
|---|---|---|---|---|---|---|
| Net Revenue ($B) | 75.1 | 74.5 | 77.0 | 81.1 | 85.2 | 98.8 |
| Net Income ($B) | 19.4 | 14.9 | 9.2 | 12.7 | 14.3 | 23.2 |
| Diluted EPS | $8.04 | $7.00 | $4.04 | $5.94 | $6.99 | $12.42 |
| ROE | 10.0% | 7.4% | 4.5% | 6.1% | 6.7% | 11.4% |
| RoTCE | 11.6% | 8.4% | 5.2% | 6.9% | 7.6% | 13.0% |
| Efficiency | 57.1% | 67.9% | 71.4% | 66.4% | 64.7% | 57.4% |
| Share Buybacks ($B) | 19.6 | 3.3 | 2.0 | 2.5 | 13.3 | 20.6 |
Restructuring Milestones
- (2026-02-18, RenCap): FY25 $1.1B , Q1'26 CET1 ~$4B . 90 → .
- Banamex () : 25%(2025) + 22.6%(Q2'26) , IPO/ . .
- OCC 2020 Consent Order (2025-12-18). FRB 2020 Order ( ·).
- KRW : FY23 239K → FY25 226K → Q2'26 219K. severance $800M+ H2 .
- CFO : Mark Mason → Gonzalo Luchetti (2026-03 ). (~$3.3B) , stranded cost $1.3B→$800M.
- AI : KRW 90% AI , 100+ . Payments Express·Wealth Advisor Insights .
4. Capital Allocation — $30B Share Buybacks & +12% Dividend Increase
C KRW . CCAR 2025 , 2026 6 $30B Buybacks ( $20B ), Q3'26 Dividend $0.60 → $0.67 (+12%) .
| Metric | FY2023 | FY2024 | FY2025 | Q2'26 |
|---|---|---|---|---|
| Share Buybacks ($B) | 2.0 | 2.5 | 13.3 | 4.0 |
| Dividend ($B) | 4.1 | 4.2 | 4.3 | ~1.0 |
| 76% | 58% | 133% | 92% | |
| Dividend | 51% | 37% | 33% | — |
- CET1 12.8% ( 11.6% +120bps) — 2028 13.1% GSIB ·Basel III .
- CCAR 2026: SCB 3.6% , DFAST SCB 3.3% 3 — ·· PPNR· . " ".
- Dividend 2.0%, TTM Share Buybacks $21.2B. KRW FY27 .
5. Valuation — Peer Discount & Return Metrics
| C | JPM | BAC | WFC | GS | MS | |
|---|---|---|---|---|---|---|
| Market Cap ($B) | 224 | 945 | 443 | 266 | 303 | 332 |
| P/E (FY26E) | 12.1x | 14.7x | 13.4x | 12.1x | 14.5x | 16.3x |
| P/E (FY27E) | 10.4x | 14.2x | 11.9x | 11.1x | 13.9x | 15.5x |
| P/B | 1.16x | 2.65x | 1.59x | 1.65x | 2.80x | 3.19x |
| P/TBV | 1.22x | 3.05x | 1.91x | 1.71x | 2.46x | 3.65x |
| ROE (TTM) | 8.4% | 17.4% | 11.2% | 12.6% | 17.1% | 17.7% |
| Dividend | 2.02% | 1.71% | 2.07% | 2.31% | 1.96% | 2.19% |
| Target Price () | $155.15 | $371.85 | $68.68 | $100.02 | $1,140 | $236.38 |
| Target Price upside | +16.2% | +5.4% | +9.9% | +13.8% | +11.0% | +11.9% |
Essence of Discount — ROE Gap
C P/B 1.16x (2.38x) . KRW , ROE 8.4%(TTM) (11~18%) . ROE .
Gordon ( 10.5%, 2.5%) P/B :
| ROE | P/B | ||
|---|---|---|---|
| 10.0% (FY26 ) | 0.94x | $108 | -19% |
| 11.4% (Q2'26 Annualized) | 1.11x | $128 | -4% |
| 13.0% (H1'26 RoTCE ) | 1.31x | $151 | +13% |
: $133.57 ROE 12% . "" ROE 12~13% . Q2'26 (Annualized ROE 11.4%), NCL (4.0~4.5% ) .
12-Month Scenario Targets
| Scenario | Probability | Target Price | Return | Premise |
|---|---|---|---|---|
| Bear | 25% | $111 | -17% | ROE 10% . NCL 5%+ , , FRB consent order , Buybacks . P/B 0.95x. |
| Base | 45% | $154 | +15% | FY26 EPS $11.1 → FY27 $12.8 , ROE 11% . FY27 P/E 12x. $155.15 . |
| Bull | 30% | $173 | +30% | RoTCE 13% , SCB , $30B Buybacks , Banamex IPO . FY27 P/E 13.5x (Target Price $176 ). |
| Probability | 100% | $149 | +12% | 12 (Dividend 2% +14%) |
6. Macro & Interest Rate Environment
| Maturity | 1M | 3M | 2Y | 5Y | 10Y | 30Y |
|---|---|---|---|---|---|---|
| (7/31) | 3.78% | 3.83% | 4.28% | 4.45% | 4.75% | 5.27% |
- (2Y→10Y +47bps, 3M→30Y +144bps): · NII . C Q2'26 NII $17.1B(+13% YoY) .
- : C Corporate/Other NII . FY26 NII +5~6% .
- : 8/3 S&P +1.48% , Financials +0.91%. IB· .
- : 8 5.4%( 7%), NCL 4.0~4.5% — ACL .
7. Analyst Consensus
| Metric | Value |
|---|---|
| Strong Buy 5 · Buy 11 · Hold 5 · Sell 0 | |
| BUY ( 76%) | |
| Target Price | $155.15 (+16.2%) |
| Target Price | $157.50 |
| Target Price | $129 ~ $176 |
| FY26E EPS | $11.08 (+47% YoY, 8 Analysts) |
| FY27E EPS | $12.83 (+15.8%, 11 Analysts) |
| Q3'26E EPS | $2.59~$2.67 (+14~18% YoY) |
: Evercore(7/17, In Line ), RBC(7/15, Outperform), Truist(7/15, Buy), BofA(7/7, Buy), UBS(7/7, Neutral). FY26 EPS +47% Q4'25 (EPS $1.19) , H1'26 $6.21 .
8. Key Risk Factors
| Risk Factor | Assessment |
|---|---|
| ① FRB 2020 Consent Order | OCC FRB order . · · . . |
| ② (NCL 4.0~4.5%) | USCC +65% NCL . 5%+ . ACL $22.2B( 2.5%) . |
| ③ KRW | $30B Buybacks CCAR/Basel III endgame/GSIB . SCB 3.3% . |
| ④ | severance $800M+. H2 + . |
| ⑤ | Equities +45% 10 . H2 -20% QoQ — . |
| ⑥ ETF 'Crash Put' | : Bloomberg (8/2) C ETF ( crash put) . ETF ~$250B — . |
| ⑦ | , NII . |
: Q2'26 ROE 11.4% (Equities +45%, IB +44%) . 2027 ROE 11%+ Services(NII +18%, $1) USCC . Bull(30%) Bear(25%) .
9. Catalyst Calendar
| Timing | Event | Expected Impact |
|---|---|---|
| 2026 H2 | severance/ | — Efficiency |
| 2026-10-13 | Q3'26 (EPS $2.59~2.67) | NII + RoTCE 10%+ |
| 2026 | Banamex (~7%) IPO/ | |
| 2027-01 | Q4'26 + CCAR 2027 | SCB 3.3% KRW |
| 2027-05 | Investor Day (2028 : RoTCE , CET1 13.1%) | |
| (10Y 4.75%, ) | NII + |
10. Conclusion & Strategic Assessment
Citigroup " + KRW + " 3 . Q2'26 RoTCE 13.0% FY23 Trough(4.9%) 3x , .
(P/B 1.16x, FWD P/E 10.4x), Target Price (+16%) . : ① ROE 12% " " , ② (4.0~4.5% NCL) H2~2027 .
Comments
💬 GitHub Discussions comment widget (Giscus integration pending)